title: NCI-MATCH Trial Draws Strong Interest.
abstract: After 800 cancer patients enrolled during the first 3 months of the NCI-MATCH trial, organizers have extended a temporary halt in enrollment to gear up for the next phase. The basket study, which matches patients to approved or experimental drugs based on specific genetic mutations in their tumors, is expected to resume in April or May.
authors.forename: Janet
authors.initials: J
authors.lastname: Colwell
mesh_terms: D000047:Academies and Institutes; D002986:Clinical Trials as Topic / Q000458:organization & administration*; D017322:Clinical Trials, Phase II as Topic; D006801:Humans; D054547:National Cancer Institute (U.S.); D014481:United States